Analyst Price Targets — AHCO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 6, 2026 11:52 am | Kevin Caliendo | UBS | $10.00 | $6.50 | TheFly | AdaptHealth price target lowered to $10 from $14 at UBS |
| August 6, 2026 10:40 am | — | RBC Capital | $8.00 | $6.50 | TheFly | AdaptHealth price target lowered to $8 from $15 at RBC Capital |
| August 5, 2026 12:40 pm | — | Truist Financial | $9.00 | $6.51 | TheFly | AdaptHealth price target lowered to $9 from $14 at Truist |
| August 5, 2026 11:29 am | Eric Coldwell | Robert W. Baird | $10.00 | $6.71 | TheFly | AdaptHealth price target lowered to $10 from $15 at Baird |
| August 5, 2026 11:00 am | — | Canaccord Genuity | $10.00 | $6.71 | TheFly | AdaptHealth price target lowered to $10 from $16 at Canaccord |
| July 21, 2026 11:33 am | Brian Tanquilut | Jefferies | $13.00 | $10.98 | StreetInsider | Jefferies Upgrades AdaptHealth (AHCO) to Buy |
| July 6, 2026 10:48 am | — | Robert W. Baird | $15.00 | $10.76 | TheFly | AdaptHealth price target lowered to $15 from $18 at Baird |
| May 11, 2026 1:35 pm | — | RBC Capital | $15.00 | $11.53 | TheFly | AdaptHealth price target raised to $15 from $13 at RBC Capital |
| May 6, 2026 11:27 am | — | Canaccord Genuity | $16.00 | $11.75 | TheFly | AdaptHealth price target raised to $16 from $14 at Canaccord |
| May 6, 2026 10:41 am | Eric Coldwell | Robert W. Baird | $18.00 | $11.75 | TheFly | AdaptHealth price target raised to $18 from $17 at Baird |
Latest News for AHCO
New platform brings four of the industry's most recognized direct-to-consumer brands together to serve the cash-pay obstructive sleep apnea (OSA) market across North America NEW YORK, Aug. 17, 2026 /PRNewswire/ -- Cathay Capital today announced the launch of ReDream Brands , a new consumer sleep health platform dedicated to helping millions of people achieve better sleep and healthier lives. The platform brings…
CONSHOHOCKEN, Pa., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims arising from the AdaptHealth Corp. (Nasdaq: AHCO) data breach.
AdaptHealth Corp. reported second quarter 2026 revenue of $740.3 million against consensus of roughly $847 million to $849 million, and a GAAP loss of $0.99 per share against expectations of approximately $0.15. Shares fell as much as 26%.
AdaptHealth NASDAQ: AHCO executives outlined the company's second-quarter performance, portfolio changes and plans to focus capital on sleep, respiratory and home medical equipment businesses during a Canaccord conference discussion.
AdaptHealth posted a huge earnings miss in Q2, and sales also came in below expectations. The company also lowered its fiscal performance targets for the year.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for AHCO.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.